2,4-di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders.
申请人:Novartis AG
公开号:EP2275413A1
公开(公告)日:2011-01-19
Novel pyrimidine derivatives of formula (I), to processes for their production, their use as IGF-1R and ALK-inhibitors in the treatment of neoplastic diseases, inflammatory and immune system disorders and to pharmaceutical compositions comprising them.
式(I)的新型嘧啶衍生物,其生产工艺,在治疗肿瘤性疾病、炎症和免疫系统疾病中作为 IGF-1R 和 ALK 抑制剂的用途,以及包含它们的药物组合物。